Data as of May 22
| -0.02 / -1.40%|
The 2 analysts offering 12-month price forecasts for Response Genetics Inc have a median target of 2.17, with a high estimate of 2.60 and a low estimate of 1.75. The median estimate represents a +54.26% increase from the last price of 1.41.
The current consensus among 2 polled investment analysts is to Buy stock in Response Genetics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.